For the month ended 30 June 2026, C-MER Medical Holdings Limited reported no changes in either authorised or issued share capital. Authorised capital stayed at 8.00 billion ordinary shares with a par value of HKD 0.10, equivalent to HKD 800.00 million.
Issued share capital also remained steady. Outstanding shares (excluding treasury shares) totalled 1,211,720,870, while treasury shares stood unchanged at 20,622,000, keeping the overall issued share count at 1,232,342,870. The company confirmed that it continued to meet the Hong Kong Exchange’s minimum 25 % public-float requirement as of month-end.
Under the Post-IPO Share Option Scheme, 133,334 options with an exercise price of HKD 7.73 were outstanding—identical to the prior month. No options were exercised or cancelled during June. The scheme still allows for up to 92,120,000 shares to be issued upon future option grants or exercises.
The filing was submitted on 2 July 2026 by Company Secretary Chan Wa Ping, with all regulatory confirmations in place.
Comments